Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001562762-19-000169
Filing Date
2019-08-06
Accepted
2019-08-06 15:19:11
Documents
63
Period of Report
2019-06-29

Document Format Files

Seq Description Document Type Size
1 10-Q usna-20190629x10q.htm   iXBRL 10-Q 2576101
2 EX-31.1 usna-20190629xex31_1.htm EX-31.1 14872
3 EX-31.2 usna-20190629xex31_2.htm EX-31.2 15146
4 EX-32.1 usna-20190629xex32_1.htm EX-32.1 6155
5 EX-32.2 usna-20190629xex32_2.htm EX-32.2 6071
  Complete submission text file 0001562762-19-000169.txt   7889591

Data Files

Seq Description Document Type Size
6 EX-101.SCH usna-20190629.xsd EX-101.SCH 34249
7 EX-101.CAL usna-20190629_cal.xml EX-101.CAL 62269
8 EX-101.DEF usna-20190629_def.xml EX-101.DEF 71202
9 EX-101.LAB usna-20190629_lab.xml EX-101.LAB 273044
10 EX-101.PRE usna-20190629_pre.xml EX-101.PRE 226467
11 EXTRACTED XBRL INSTANCE DOCUMENT usna-20190629x10q_htm.xml XML 1756861
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 10-Q | Act: 34 | File No.: 001-35024 | Film No.: 191001735
SIC: 2833 Medicinal Chemicals & Botanical Products